NCT05283733

Brief Summary

A Prospective Randomized Controlled Trial of Reverse Conversion (Open to Laparoscopic) in management of Acute Perforated Appendicitis

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
426

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 18, 2018

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2021

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 25, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 18, 2022

Completed
27 days until next milestone

First Posted

Study publicly available on registry

March 17, 2022

Completed
Last Updated

March 17, 2022

Status Verified

March 1, 2022

Enrollment Period

3.9 years

First QC Date

February 18, 2022

Last Update Submit

March 16, 2022

Conditions

Keywords

laparoscopicappendectomyreverse conversionreoperationintraabdominal abscesses

Outcome Measures

Primary Outcomes (4)

  • the rates of intraabdominal abscess

    rates of complications

    3 months post operative

  • rates of wound infection

    rates of complications

    3 months post operative

  • rates of ileus

    Baseline (Hospital admission)

  • rates of reoperation

    3 months post operative

Secondary Outcomes (2)

  • The hospital length of stay

    up to 3 months

  • the operative time

    Intraoperative

Study Arms (2)

group A

EXPERIMENTAL

the group who was subjected to the reverse conversion technique

Procedure: reverse conversion technique

group B

NO INTERVENTION

the control group who was completed by open technique

Interventions

converting open appendectomy to laparoscopic technique for proper control of intraabdominal sepsis

Also known as: laparoscopic lavage
group A

Eligibility Criteria

Age16 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • symptoms consistent with acute perforated appendicitis,
  • had ultrasound or computed tomography (CT) evidence of acute perforated appendicitis,
  • ages ranging from 16 to 65 years.

You may not qualify if:

  • radiological evidence of appendicular mass,
  • septic shock or multi-organ failure (MOF) at presentation,
  • Diabetes Mellitus (DM), renal failure, morbid obesity
  • recent (6-month) history of thromboembolic disease
  • immunomodulators,
  • a history of inflammatory bowel disease (IBD),
  • postoperative pathological report of the removed appendix revealed carcinoid or Crohn's disease,
  • American Society of Anesthesiology (ASA) classification more than II.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zagazig University

Zagazig, Egypt

Location

MeSH Terms

Conditions

SepsisAbdominal Abscess

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsAbscessSuppuration

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

February 18, 2022

First Posted

March 17, 2022

Study Start

January 18, 2018

Primary Completion

December 15, 2021

Study Completion

December 25, 2021

Last Updated

March 17, 2022

Record last verified: 2022-03

Locations